Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Forms strategic alliance with the American Lung Association on a year-long awareness program targeting the growing number of upper respiratory disorders in the U.S. Beginning with "Breathe Easier American Week" on Oct. 18-22, Sandoz' Tavist-1 and Tavist-D products will be used to sponsor the compaign supported by educational material from ALA. The national education program will be supported through national print and broadcast advertising as well as in-store promotions. Consumers can receive an educational kit containing literature on upper respiratory ailments from ALA by calling a toll-free number accompanying the ads. A percentage of product sales of Tavist-1 and Tavist-D will go to ALA. Sandoz also has pledged $ 750,000 to ALA.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts